S&P 500
$5,911.16
+1.9%
+$108.34
DJI
$42,253.52
+1.6%
+$650.45
NASDAQ
$19,167.75
+2.3%
+$430.54
Bitcoin
110,384.00
+0.8%
+872.52
AAPL
$199.98
+2.4%
+$4.71
AMZN
$206.10
+2.5%
+$5.11
GOOG
$173.43
+2.3%
+$3.84
META
$641.12
+2.2%
+$14.06
MSFT
$458.61
+1.9%
+$8.43
NVDA
$135.26
+3.0%
+$3.98
TSLA
$360.70
+6.3%
+$21.36
ETF Series Solutions - Range Cancer Therapeutics ETF (NASDAQ: CNCR)
$8.91
(0.1%)
$0.01
Price as of May 19, 2025, 1:56 p.m. ET
ETF Series Solutions - Range Cancer Therapeutics ETF Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ETF Series Solutions - Range Cancer Therapeutics ETF Company Info
Loncar Cancer Immunotherapy ETF
News & Analysis
Featured Article
3 Index Funds to Buy in August
Our contributors take a look at three index funds in promising areas such as emerging markets, cancer immunotherapy, and banks.
Andrés Cardenal, Jason Hall, and George Budwell | Aug 1, 2016
Featured Article
3 High-Growth ETFs to Supercharge Your Portfolio
Exposing your portfolio to high-growth industries while staying diversified is a way to boost your portfolio with less risk.
Cory Renauer, Matt Frankel, and Brian Feroldi | Jun 1, 2016
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.